Literature DB >> 15281278

[pRB, p53, p16INK4a, senescence and malignant transformation].

Christian-Jacques Larsen1.   

Abstract

Recent works aimed at clarifying the respective roles of p16INKa and p14ARF (both located on the same INK4a locus on chromosome 9p21 in man) in malignant transformation come to the conclusion that p16INK4a is the true tumor suppressor gene in man. In mouse, it is the p19ARF knockout that suppresses the barrier protecting cells from malignant transformation. This situation is in agreement with p19ARF- and p16-mediated senescence induced by oncogenic mutated ras (Ras*) in mouse and man respectively. Other results have shown that senescence in human diploid fibroblasts is associated with heterochromatin occurrence that maintains in repressed state E2F1-induced gens required for G1 to S phases transition. Since RB protein is responsible for this chromatin modification, cells with any impaired RB pathway cannot enter into senescence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15281278

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  4 in total

1.  Interaction among Rb/p16, Rb/E2F1 and HDAC1 proteins in gallbladder carcinoma.

Authors:  Xin Wang; Kai Huang; Lining Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-12-29

Review 2.  Preserving and rejuvenating old organs for transplantation: novel treatments including the potential of senolytics.

Authors:  Tomohisa Matsunaga; Maximilian J Roesel; Andreas Schroeter; Yao Xiao; Hao Zhou; Stefan G Tullius
Journal:  Curr Opin Organ Transplant       Date:  2022-08-09       Impact factor: 2.269

3.  Assessment of transformed properties in vitro and of tumorigenicity in vivo in primary keratinocytes cultured for epidermal sheet transplantation.

Authors:  A Thépot; A Desanlis; E Venet; L Thivillier; V Justin; A P Morel; F Defraipont; M Till; V Krutovskikh; M Tommasino; O Damour; P Hainaut
Journal:  J Skin Cancer       Date:  2010-09-19

Review 4.  Senolytic drugs: from discovery to translation.

Authors:  J L Kirkland; T Tchkonia
Journal:  J Intern Med       Date:  2020-08-04       Impact factor: 13.068

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.